Clinical Trial Update: Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating single-dose and twice-daily dosing of ramipril and its effect on renal function in patients with chronic kidney disease a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Ramipril (ramipril)

Snippet

Sponsor: Evi Liliek Wulandari | Conditions: Chronic Kidney Disease, Heart Failure With Reduced Ejection Fraction (HFrEF) | Phase 4 | Status: RECRUITING